Medpace is a leading clinical contract research organization that provides outsourced clinical development services to biotechnology, pharmaceutical, and medical device companies across all therapeutic phases. The company offers comprehensive Phase I–IV clinical development services including clinical operations, regulatory expertise, laboratory and analytical services, and on-site clinical facilities, with particular strength in oncology, metabolic, cardiology, antiviral, and central nervous system therapeutic areas. Medpace generates revenue by delivering full-service clinical trial management and drug development support to a diversified customer base of small, mid-sized, and large pharmaceutical companies, competing on the basis of therapeutic expertise, execution quality, global infrastructure, and speed to market.